CIK 0001761918 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Erasca, Inc.
Sign in to watch- Ticker
- ERAS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831217027
- Phone
- (858) 465-6511
- Business address
- 3115 MERRYFIELD ROW, THIRD FLOOR, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 10 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-03 | Lim Jonathan E Chairman & CEO | Grant or award · Stock option (right to buy) | +2,500,000 | 2,500,000 | ||
| 2025-01-07 | Garner Ebun General Counsel & Corp. Sec. | Option exercise · Stock Option (right to buy) 10b5-1 | −120,000 | 360,000 | ||
| 2025-01-01 | Casdin Alexander W. Director | Grant or award · Stock Option (right to buy) | +28,877 | 28,877 | ||
| 2025-01-01 | LIU JEAN I Director | Grant or award · Stock Option (right to buy) | +24,939 | 24,939 | ||
| 2025-01-01 | Start Valerie Denise Harding Director | Grant or award · Stock Option (right to buy) | +29,402 | 29,402 | ||
| 2025-01-01 | Bristol James Arthur Director | Grant or award · Stock Option (right to buy) | +45,678 | 45,678 | ||
| 2024-12-13 | Chacko David M. CFO and CBO | Other acquisition | +12,324 | $1.56 | $19K | 262,187 |
| 2024-12-13 | Garner Ebun General Counsel & Corp. Sec. | Other acquisition | +5,731 | $1.56 | $9K | 21,174 |
| 2024-06-20 | Varney Michael David Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2024-06-20 | Start Valerie Denise Harding Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2024-06-20 | LIU JEAN I Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2024-06-20 | Garner Ebun General Counsel & Corp. Sec. | Grant or award · Stock Option (right to buy) | +160,082 | 160,082 | ||
| 2024-06-20 | Morris Shannon Chief Medical Officer | Grant or award · Stock Option (right to buy) | +137,142 | 137,142 | ||
| 2024-06-20 | Lim Jonathan E Chairman & CEO | Grant or award · Stock Option (right to buy) | +632,759 | 632,759 | ||
| 2024-06-20 | Chacko David M. CFO and CBO | Grant or award · Stock Option (right to buy) | +278,812 | 278,812 | ||
| 2024-06-20 | Hambleton Julie Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2024-06-20 | Casdin Alexander W. Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2024-06-20 | Bristol James Arthur Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2024-06-20 | Multani Pratik S Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2024-06-14 | Chacko David M. CFO and CBO | Other acquisition | +3,137 | $1.56 | $5K | 262,187 |
Page 3 of 7 · 121 trades